global Addison’s Disease Market

1. Orion Market Research Addison’s Disease Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027 Request a Free Sample @ https://www.omrglobal.com/request-sample/addison-disease- market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global Addison’s Disease Market is anticipated to grow at a considerable CAGR during the forecast period (2021-2027). The growth of the market is mainly attributed to the increase in the prevalence of Addison’s disease, rising R&D activities to produce new drugs for diagnosis and increasing awareness about Addison’s disease among the population across the globe. The advancement in technologies and several government initiatives also played a vital role in contributing to the growth of the market. Besides, major market players such as Pfizer Inc. GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Novartis AG are adopting various strategies such as mergers & acquisition, new product launches, business expansion, and technology innovation to remain competitive in the market. To @ https://www.omrglobal.com/request-sample/addison-disease-market learn more about this report request a sample copy The approvals from the FDA for the drugs produced by major market players expected to propel the growth of the market. For instance, in September 2020, Diurnal Group plc had announced that the US Food and Drug Administration (FDA) has approved Alkindi Sprinkle (hydrocortisone granules in capsules for opening). The Alkindi Sprinkle is the replacement therapy for adrenal insufficiency (AI) in infants, children and adolescents (from birth to <18 years old). Besides, the strategic partnership among the market players is also growing which lead to the production of these medicines on a larger level. For instance, Citrine Medicine, a China-based rare disease therapeutics company had announced a partnership collaboration with Diurnal Group Plc to develop, register and commercialization Alkindi in the China market. However, the lack of awareness and inability to diagnose Addison’s disease in starting phase can be a restrain to market growth. further, the investment and initiatives by many pharmaceutical companies can offer lucrative opportunities in the market. Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/addison- disease-market Global Addison’s Disease Market Report Segment By Diagnosis Laboratory Testing Imaging By Treatment Oral Corticosteroids Corticosteroids Injections By End-User Hospitals and Clinics

3. Diagnostic Laboratories Global Addison’s Disease Market Report Segment by Region North America United States Canada Europe UK Germany Italy Spain France Russia Rest of Europe Asia-Pacific China India Japan South Korea Rest of Asia-Pacific Rest of the World Latin America Middle East & Africa Company Profiles Boehringer Ingelheim International GmbH. Diurnal Group plc GlaxoSmithKline plc Laboratory Corporation of America Lupin Pharmaceuticals, Inc., Merck KGaA Novartis AG Pfizer Inc.

4. Tocris Bioscience 7.10. Trinity Biotech PLC ViroPharma For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/addison-disease-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404